Biocept reported $10.47M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 44M
Becton, Dickinson and BDX:US $ 1.15B 83M
Biocept BIOC:US $ 10.47M 5.22M
Celldex Therapeutics CLDX:US $ 7.15M 243K
Cerulean Pharma CERU:US $ 2.59M 168.34K
Cytori Therapeutics CYTX:US $ 2.29M 148K
General Electric GE:US $ 2.7B 92M
Illumina ILMN:US $ 410M 102M
Quest Diagnostics DGX:US $ 422M 6M
Thermo Fisher Scientific TMO:US $ 1.74B 537M